Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 10 September 2012 | By Ansis Helmanis,
Brazil's National Health Surveillance Agency (Anvisa) and the National Council for Scientific and Technological Development (CNPq) are partnering on an initiative to financially support projects that would "significantly contribute" to innovation in the regulatory sciences, Anivsa said in a 4 September announcement.
Both CNPq -- a government agency that acts to promote science in technology in Brazil -- and Anvisa jointly published on 31 August a public notice requesting the submission of proposed regulatory science projects by 13 October 2012.
The notice identified 8 lines of regulatory science technologies research that would qualify for funding, including those that would address disease transmission through blood, tissues, cells and organs, with emphasis on endemic and emerging diseases, and the evaluation and validation of the quality of in vitro diagnostic products.
Read more:
Anvisa - Anvisa and CNPq call to publish research in health surveillance
Read all Breaking News from RegLink
Tags: IVDs, CNPq, regulatory science